References
- 1. Anjorin AA. The coronavirus disease 2019 (COVID-19) pandemic: A review and an update on cases in Africa. Asian Pac J Trop Med. 2020;13:99-203. doi: 10.4103/1995-7645.281612.10.4103/1995-7645.281612
- 2. Akçay Ş, Ozlu T, Yılmaz A. Radiological approaches to COVID-19 pneumonia. Turk J Med Sci. 2020;50:604-610. doi: 10.3906/sag-2004-160.10.3906/sag-2004-160719598732299200
- 3. Abobaker A, Raba AA, Alzwi A. Extrapulmonary and atypical clinical presentations of COVID-19. J Med Virol. 2020;92:2458-2464. doi: 10.1002/jmv.26157.10.1002/jmv.26157730050732520401
- 4. Jin J. Screening for cardiovascular disease risk with ECG. JAMA. 2018;319:2346. doi: 10.1001/jama.2018.7311.10.1001/jama.2018.731129896628
- 5. Supreeth RN, Francis J. Fragmented QRS-Its significance. Indian Pacing Electrophysiol J. 2020;20:27-32. doi: 10.1016/j.ipej.2019.12.005.10.1016/j.ipej.2019.12.005699439631843558
- 6. Bektaş O, Çerik IB, Çerik HÖ, et al. The relationship between severe acute respiratory syndrome coronavirus 2 (SARSCOV-2) pandemic and fragmented QRS. J Electrocardiol. 2020;62:10-13. doi: 10.1016/j.jelectrocard.2020.07.009.10.1016/j.jelectrocard.2020.07.009737527132736117
- 7. Barman HA, Atici A, Alici G, et al. The effect of the severity COVID-19 infection on electrocardiography. Am J Emerg Med. 2021;46:317-322. doi: 10.1016/j.ajem.2020.10.005.10.1016/j.ajem.2020.10.005753992733059987
- 8. Mccullough SA, Goyal P, Krishnan U, Cho JJ, Safford MM, Okın PM. Electrocardiographic findings in coronavirus disease-19: insights on mortality and underlying myocardial processes. J Card Fail. 2020;26:626-632. doi: 10.1016/j.cardfail.2020.06.005.10.1016/j.cardfail.2020.06.005729351832544622
- 9. Angeli F, Spanevello A, De Pontia R, et al. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020;78:101-106. doi: 10.1016/j.ejim.2020.06.015.10.1016/j.ejim.2020.06.015730592832586646
- 10. Yenerçağ M, Arslan U, Şeker O, et al. Evaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019. J Cardiovasc Med. 2021;22:197-203. doi: 10.2459/JCM.0000000000001135.10.2459/JCM.000000000000113533186236
- 11. Ozcan S, Cakmak HA, Ikitimur B, et al. The prognostic significance of narrow fragmented QRS on admission electrocardiogram in patients hospitalized for decompensated systolic heart failure. Clin Cardiol. 2013;36:560-564. doi: 10.1002/clc.22158.10.1002/clc.22158664952223754185
- 12. Milano SS, de Moura Júnior OV, Souza Bordin AA, Marques GL. C-reactive protein is a predictor of mortality in ST-segment elevation acute myocardial infarction. Int J Cardiovasc Sci. 2019;32:118-124. doi: 10.5935/2359-4802.20180086.10.5935/2359-4802.20180086
- 13. Shrivastava AK, Singh HV, Raizada A, Singh SK. C-reactive protein, inflammation and coronary heart disease. Egypt Heart J. 2015;67:89-97. doi: 10.1016/j.ehj.2014.11.005.10.1016/j.ehj.2014.11.005
- 14. Efe SÇ, Candan ÖÖ, Gündoğan C, et al. Value of C-reactive protein/albumin ratio for predicting ischemia in myocardial perfusion scintigraphy. Mol Imaging Radionucl Ther. 2020;29:112-117. doi: 10.4274/mirt.galenos.2020.88261.10.4274/mirt.galenos.2020.88261758374933094574
- 15. Santos HO, Moreira Izidoro LF. Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment. Int J Cardiovasc Sci. 2018;31:532-537. doi: 10.5935/2359-4802.20180038.10.5935/2359-4802.20180038
- 16. Ataoğlu HE, Yılmaz F, Uzunhasan I, et al. Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res. 2010;38:52-61. doi: 10.1177/147323001003800106.10.1177/14732300100380010620233513
- 17. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129-2200. doi: 10.1093/eurheartj/ehw128.10.1093/eurheartj/ehw12827206819
- 18. Yiğit Ö, Cete Y, Eken C, Göksu E. The sensitivity and specificity of high sensitive CRP, d-dimer and IL-6 in acute coronary syndrome. Balkan Med J. 2011;28:429-434. doi: 10.5152/balkanmedj.2011.010.10.5152/balkanmedj.2011.010
- 19. Panagopoulou V, Deftereos S, Kossyvakis C, et al. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem. 2013;13:82-94. doi: 10.2174/1568026611313020002.10.2174/156802661131302000223470072
- 20. Kocaman SA, Çetin M, Kırış T, et al. The importance of fragmented QRS complexes in prediction of myocardial infarction and reperfusion parameters in patients undergoing primary percutaneous coronary intervention. Turk Kardiyol Dern Ars. 2012;40:213-222. doi: 10.5543/tkda.2012.36937.10.5543/tkda.2012.3693722864316
- 21. Radwan HI, Mansour KS, Al-Daydamony MM, Mohammed RS. Fragmented QRS complex as a predictor of high risk in acute coronary syndrome. Cardiol Cardiovasc Res. 2019;3:71-79. doi: 10.11648/j.ccr.20190303.16.10.11648/j.ccr.20190303.16
- 22. Zhao Q, Zhang Q, Hou J, Yu B. Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention. Acta Cardiol Sin. 2018;34:13-22. doi: 10.6515/ACS.201801_34(1).20170903A.